Key facts
- Aidoc’s last known valuation is $686.4M (Jun 2022).
- It has raised $420.3M; the latest was Later Stage VC ($150.0M) in Jul 2025.
- Notable investors include Google for Startups, General Catalyst, Microsoft for Startups, NVentures (Santa Clara), Amazon Web Services — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Aidoc
- ·The full record, as it builds
Funding rounds
No funding rounds for Aidoc are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aidoc
Developer of a decision support platform designed to empower physicians to enhance patient care outcomes. The company's platform processes medical imaging and patient data using advanced artificial intelligence algorithms to detect critical anomalies and activate the appropriate care pathway within the health system, enabling radiology, cardiology, neurovascular and vascular physicians to get comprehensive clinical data for patient outcomes.
- Sector
- Healthcare
- HQ
- Tel Aviv, NY, Israel
- Founded
- 2016
- Employees
- 488
- Website
- aidoc.com/
- Ownership
- Privately Held (backing)
Aidoc doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aidoc shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aidoc in its N-PORT filings yet. We sweep new filings monthly.